The Envision Pharma Group has launched a set of behavioural science-led solutions

The Envision Pharma Group, a leading global technology-enabled scientific communications company, has launched a set of behavioural science-led solutions to increase the group’s capabilities to optimise value offering to its clients.

Supported by directors Justine Swann and Jenny Squibbs, while being spearheaded by Mark Lakeram, Envision the Change has a dedicated team of behavioural scientists who understand that intricacies and realities of day-to-day health and life need to be considered to affect real change.

Lakeram stated, “All healthcare decisions are influenced by human behaviour. By taking into account the science behind this, our proprietary Feel-Think-DoTM model helps to decode why people make the decisions they do. From strategic and tactical planning to aiding information recall through data visualization and adult learning techniques, we provide counsel and support to drive behaviour change that ultimately improves health outcomes.”

Head of Envision Scientific Solutions, Susanne Clark, stated: “No matter what product challenges are ahead, understanding the behaviour of key stakeholders will be paramount. I’m delighted that we’ve strengthened our service offering with Envision the Change in order to support our clients across all aspects of medical affairs and marketing, from planning to creative implementation for both external and internal audiences.”